Citation Impact
Citing Papers
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 Standout
The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly
2008
Partial Surgical Removal of Growth Hormone-Secreting Pituitary Tumors Enhances the Response to Somatostatin Analogs in Acromegaly
2006
Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria
2005 StandoutScience
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
2008 Standout
Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation
2009
Human Growth Hormone Abuse in Male Weightlifters
2010
Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide
2003
Acromegaly
2006 Standout
Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?
2001
Morbidity after Long-Term Remission for Acromegaly: Persisting Joint-Related Complaints Cause Reduced Quality of Life
2005
Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden
2002
Preoperative Octreotide Treatment in Newly Diagnosed Acromegalic Patients with Macroadenomas Increases Cure Short-Term Postoperative Rates: A Prospective, Randomized Trial
2008
Cardiac Effect of Thyrotoxicosis in Acromegaly1
2000
Cancers Associated with Acromegaly
2006
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
Pharmacotherapy or Surgery as Primary Treatment for Acromegaly?
2000
Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patients
2007
Risk of Thyroid Nodular Disease and Thyroid Cancer in Patients with Acromegaly – Meta-Analysis and Systematic Review
2014
Acromegaly: Re-thinking the cancer risk
2007
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
2008
Acromegaly, growth hormone and cancer risk
2008
Risk Factors for Cerebrovascular Deaths in Patients Operated and Irradiated for Pituitary Tumors
2002
Cushing's syndrome
2015 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Growth Hormone Receptor Antagonists
2004
Is the Acromegalic Cardiomyopathy Reversible? Effect of 5-Year Normalization of Growth Hormone and Insulin-Like Growth Factor I Levels on Cardiac Performance*
2001
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon
1999
Diagnosis and Treatment of Pituitary Tumors
1999
Medical consequences of acromegaly: What are the effects of biochemical control?
2007
Effect of transsphenoidal surgery on sleep apnoea in acromegaly
2007
Variation in GH and IGF‐I assays limits the applicability of international consensus criteria to local practice
2007
Epidemiology of Prostate Cancer
2019 Standout
Hormonal and Metabolic Effects of Radiotherapy in Acromegaly: Long-Term Results in 128 Patients Followed in a Single Center
2000
Maternal and child undernutrition: consequences for adult health and human capital
2008 Standout
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance
2000
Ghrelin Increases Energy Intake in Cancer Patients with Impaired Appetite: Acute, Randomized, Placebo-Controlled Trial
2004
Height, Leg Length, and Cancer Risk: A Systematic Review
2001
Early Vascular Alterations in Acromegaly
2002
Thyroid cancer is the most common cancer associated with acromegaly
2010
Comparison between Six-Year Therapy with Long-Acting Somatostatin Analogs and Successful Surgery in Acromegaly: Effects on Cardiovascular Risk Factors
2006
Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR®
2008
Serum lipoprotein changes following IGF‐I normalization using a growth hormone receptor antagonist in acromegaly
2002
Association between premature mortality and hypopituitarism
2001
Gamma knife radiosurgery for acromegaly – long‐term experience
2006
Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors
2005 Standout
Growth Hormone and Pituitary Radiotherapy, But Not Serum Insulin-Like Growth Factor-I Concentrations, Predict Excess Mortality in Patients with Acromegaly
2004
Does the GH–IGF axis play a role in cancer pathogenesis?
2000
Primary medical therapy for acromegaly
2003
Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?
1999
Epidemiology of Acromegaly
1999
Excess mortality for patients with residual disease following resection of pituitary adenomas
2011
Increased arterial intima‐media thickness by B‐M mode echodoppler ultrasonography in acromegaly
2001
Elevated incidence of sleep apnoea in acromegaly—correlation to disease activity
2012
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Cancer-associated cachexia
2018 Standout
Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins
2000
Primary Treatment of Acromegaly with Octreotide LAR: A Long-Term (Up to Nine Years) Prospective Study of Its Efficacy in the Control of Disease Activity and Tumor Shrinkage
2006
Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly
2004
Acute leukaemia in acromegaly patients
2000
Risk of Second Brain Tumor after Conservative Surgery and Radiotherapy for Pituitary Adenoma: Update after an Additional 10 Years
2005
The Role of Obesity and Related Metabolic Disturbances in Cancers of the Colon, Prostate, and Pancreas
2007
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Characterization of premature atherosclerosis of carotid arteries in acromegalic patients
2001
CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem?
2001
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly
2009
Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly
2002
Failure of radiotherapy in acromegaly
2001
Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients
2013
The Importance of Locating a Good Pituitary Surgeon
1999
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Acromegaly and cancer risk: a cohort study in Sweden and Denmark
2002
Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis?
2011
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
2002 Standout
Childhood growth and adult cancer
2002
Akt regulates growth by directly phosphorylating Tsc2
2002 Standout
Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
1997
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
2001
Polycystic Ovary Syndrome
2005 Standout
Cerebrovascular mortality in patients with pituitary adenoma
2002
Insulin and insulin resistance:
2004 Standout
Growth hormone and physical performance
2011
Determinants of Survival in Treated Acromegaly in a Single Center: Predictive Value of Serial Insulin-Like Growth Factor I Measurements
2004
Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction
2000
A Nationwide Survey of Mortality in Acromegaly
2005
The octreotide test dose is not a reliable predictor of the subsequent response to somatostatin analogue therapy in patients with acromegaly
2006
Conventional Pituitary Irradiation Is Effective in Lowering Serum Growth Hormone and Insulin-Like Growth Factor-I in Patients with Acromegaly
2006
CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem
2001
Risk of colorectal neoplasia in acromegaly: an independent view*
2001
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
The Role of Pharmacotherapy in Perioperative Management of Patients with Acromegaly
2003
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
2008
Effect of Growth Hormone (GH) and Insulin-Like Growth Factor I on Prostate Diseases: An Ultrasonographic and Endocrine Study in Acromegaly, GH Deficiency, and Healthy Subjects
1999
Ghrelin: Structure and Function
2005 Standout
Growth hormone and the heart
2001
Factors Influencing Mortality in Acromegaly
2004
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’
2005
Self Image and Quality of Life in Acromegaly
2002
Screening colonoscopy for acromegaly in perspective*
2001
Systemic Hypertension and Impaired Glucose Tolerance Are Independently Correlated to the Severity of the Acromegalic Cardiomyopathy1
2000
Gender- and age-related differences in the endocrine parameters of acromegaly
2002
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA)
2004
Gender and age influence the relationship between serum GH and IGF‐I in patients with acromegaly
2002
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
2004 Standout
Pituitary Tumor Registry: A Novel Clinical Resource1
2000
Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly
2004
Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy
2005
Hormonal regulation of longevity in mammals
2007
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
2004 Standout
Partial Deletion of Pten in the Hypothalamus Leads to Growth Defects that Cannot be Rescued by Exogenous Growth Hormone
2008 StandoutNobel
A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly
2008
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
Acromegaly—Consensus, What Consensus?
2002
Impact of Treating Acromegaly First with Surgery or Somatostatin Analogs on Cardiomyopathy
2008
Insulin Resistance and Its Contribution to Colon Carcinogenesis
2003
Management of growth hormone deficiency in adults
2007
Optimizing Control of Acromegaly: Integrating a Growth Hormone Receptor Antagonist into the Treatment Algorithm
2003
Control of growth hormone and IGF 1 in patients with acromegaly in the UK : responses to medical treatment with somatostatin analogues and dopamine agonists
2013
Fasting and cancer treatment in humans: A case series report
2009 Standout
Mortality in Acromegaly: A Metaanalysis
2007
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Diabetes and Cancer
2010 Standout
Relationship between Disease-Related Morbidity and Biochemical Markers of Activity in Patients with Acromegaly
2005
A Consensus on Criteria for Cure of Acromegaly
2010
Evolutionary Medicine: From Dwarf Model Systems to Healthy Centenarians?
2003 Science
Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
2010
The Prevalence and Characteristics of Colorectal Neoplasia in Acromegaly
2000
Incidence of Malignant Tumors in Patients with Acromegaly
2000
Minireview: Role of the Growth Hormone/Insulin-Like Growth Factor System in Mammalian Aging
2005
A Paradigm Shift in the Monitoring of Patients With Acromegaly: Last Available Growth Hormone May Overestimate Risk
2013
Mortality in Patients with Pituitary Disease
2010
Effect of Sex and Assay Method on Serum Concentrations of Growth Hormone in Patients with Acromegaly and in Healthy Controls
2006
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant
2003
Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-I, and Tumor Size
2002
Physiological Functions of Pten in Mouse Tissues.
2003 StandoutNobel
Hypertension in acromegaly and in the normal population: prevalence and determinants
2005
Cardiovascular Effects of Depot Long-Acting Somatostatin Analog Sandostatin LAR in Acromegaly*
2000
Essential Role of Pten in Body Size Determination and Pancreatic β-Cell Homeostasis In Vivo
2006 StandoutNobel
Acromegaly: historical perspectives and current therapy
2001
Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates
2006
How Matrix Metalloproteinases Regulate Cell Behavior
2001 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice
2002
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
2011 StandoutNobel
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
Cardiovascular Function in Acromegaly
2003
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
2011
High Prevalence of Cardiac Valve Disease in Acromegaly: An Observational, Analytical, Case-Control Study
2003
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
2012
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
2016 Standout
Global Fibrinolytic Capacity Is Decreased in Polycystic Ovary Syndrome, Suggesting a Prothrombotic State
2002
Monitoring disease activity using GH and IGF‐I in the follow‐up of 501 patients with acromegaly
2009
Autophagy in Health and Disease: A Double-Edged Sword
2004 StandoutScience
Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis
2007
Works of Stephen M. Orme being referenced
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
1998
The Effects of Insulin-Like Growth Factor-1 on Plasminogen Activator Inhibitor-1 Synthesis and Secretion: Results from In Vitro and In Vivo Studies
1993